Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960897154> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2960897154 endingPage "5779" @default.
- W2960897154 startingPage "5779" @default.
- W2960897154 abstract "Abstract Background: Ex-vivo T-cell-depleted graft is used to prevent acute and chronic GVHD for haploidentical hematopoietic SCT (HSCT). We conducted a systematic review and meta-analysis to evaluate the outcomes of T-cell-depleted grafts for peripheral blood haploidentical stem cell transplantation in patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Method: A comprehensive literature search on PubMed, Embase, Cochrane and Web of Science was conducted up to July 25, 2018. Two independent reviewers screened the literature and extracted data. The methodological quality was assessed using modified Newcastle-Ottawa Scale. CMA software v.3 was used for the analysis. Heterogeneity among studies was assessed using the I2 test. Random-effect model was applied. Results: The search strategy identified over 550 articles; three studies (n = 404 patients; 1 prospective; 1 multi-center) were selected for this meta-analysis. The sample size of the studies varied between 34 and 266 patients. The median follow-up ranged from 6 to 47 months. Two studies (Aversa, F. et al. 2005)(n=104 patients); (Ciceri, F. et al. 2008)(n=266 patients) used CD34+ selected cells and other study used TCR-αβ depleted PBSC graft (Kaynar, L. et al. 2016) (n=34). All studies used myeloablative (MA) conditioning. In vivo T-cell-depletion by ATG was used in two studies. Two studies using mega-dose of CD34+ did not use GVHD prophylaxis and other study with αβ T-cell depleted graft used mycophenolate mofetil (MMF). Engraftment rates ranged from 91% to 98%. Pooled rates (95%CI) of grade II-IV, III-IV aGVHD and chronic GVHD were 9% (4-20; I2=82%), 4.8% (1.7-13.1; I2=78%) and 10.7% (6.3-17.6; I2=64%), respectively. The pooled estimates (95%CI) showed a 2-year disease-free survival (DFS) rate of 30.8% (24.2-38.3; I2=54%), 2-year relapse incidence of 21.5% (17.4-26.2; I2=85%). The results are shown in figure 1. Conclusion: T-cell-depleted peripheral blood stem cell graft for haploidentical transplantation in acute leukemia may be an alternative treatment option. Larger prospective studies are needed to evaluate the outcomes of different manipulation techniques. Disclosures No relevant conflicts of interest to declare." @default.
- W2960897154 created "2019-07-23" @default.
- W2960897154 creator A5005991606 @default.
- W2960897154 creator A5009003215 @default.
- W2960897154 creator A5011970860 @default.
- W2960897154 creator A5018470139 @default.
- W2960897154 creator A5028095538 @default.
- W2960897154 creator A5035588054 @default.
- W2960897154 creator A5036696622 @default.
- W2960897154 creator A5037143476 @default.
- W2960897154 creator A5048273697 @default.
- W2960897154 creator A5058632801 @default.
- W2960897154 creator A5061055639 @default.
- W2960897154 creator A5062279447 @default.
- W2960897154 creator A5071061366 @default.
- W2960897154 creator A5073268835 @default.
- W2960897154 creator A5074631288 @default.
- W2960897154 date "2018-11-29" @default.
- W2960897154 modified "2023-09-30" @default.
- W2960897154 title "Outcomes of T-Cell Depleted Haploidentical Peripheral Blood Stem Cell Transplantation for Adult Acute Leukemia: A Meta-Analysis" @default.
- W2960897154 doi "https://doi.org/10.1182/blood-2018-99-115592" @default.
- W2960897154 hasPublicationYear "2018" @default.
- W2960897154 type Work @default.
- W2960897154 sameAs 2960897154 @default.
- W2960897154 citedByCount "0" @default.
- W2960897154 crossrefType "journal-article" @default.
- W2960897154 hasAuthorship W2960897154A5005991606 @default.
- W2960897154 hasAuthorship W2960897154A5009003215 @default.
- W2960897154 hasAuthorship W2960897154A5011970860 @default.
- W2960897154 hasAuthorship W2960897154A5018470139 @default.
- W2960897154 hasAuthorship W2960897154A5028095538 @default.
- W2960897154 hasAuthorship W2960897154A5035588054 @default.
- W2960897154 hasAuthorship W2960897154A5036696622 @default.
- W2960897154 hasAuthorship W2960897154A5037143476 @default.
- W2960897154 hasAuthorship W2960897154A5048273697 @default.
- W2960897154 hasAuthorship W2960897154A5058632801 @default.
- W2960897154 hasAuthorship W2960897154A5061055639 @default.
- W2960897154 hasAuthorship W2960897154A5062279447 @default.
- W2960897154 hasAuthorship W2960897154A5071061366 @default.
- W2960897154 hasAuthorship W2960897154A5073268835 @default.
- W2960897154 hasAuthorship W2960897154A5074631288 @default.
- W2960897154 hasBestOaLocation W29608971541 @default.
- W2960897154 hasConcept C10205521 @default.
- W2960897154 hasConcept C126322002 @default.
- W2960897154 hasConcept C143998085 @default.
- W2960897154 hasConcept C203014093 @default.
- W2960897154 hasConcept C2776863199 @default.
- W2960897154 hasConcept C2777408962 @default.
- W2960897154 hasConcept C2778461978 @default.
- W2960897154 hasConcept C2778729363 @default.
- W2960897154 hasConcept C28328180 @default.
- W2960897154 hasConcept C2911091166 @default.
- W2960897154 hasConcept C54355233 @default.
- W2960897154 hasConcept C71924100 @default.
- W2960897154 hasConcept C86803240 @default.
- W2960897154 hasConcept C90924648 @default.
- W2960897154 hasConcept C95190672 @default.
- W2960897154 hasConceptScore W2960897154C10205521 @default.
- W2960897154 hasConceptScore W2960897154C126322002 @default.
- W2960897154 hasConceptScore W2960897154C143998085 @default.
- W2960897154 hasConceptScore W2960897154C203014093 @default.
- W2960897154 hasConceptScore W2960897154C2776863199 @default.
- W2960897154 hasConceptScore W2960897154C2777408962 @default.
- W2960897154 hasConceptScore W2960897154C2778461978 @default.
- W2960897154 hasConceptScore W2960897154C2778729363 @default.
- W2960897154 hasConceptScore W2960897154C28328180 @default.
- W2960897154 hasConceptScore W2960897154C2911091166 @default.
- W2960897154 hasConceptScore W2960897154C54355233 @default.
- W2960897154 hasConceptScore W2960897154C71924100 @default.
- W2960897154 hasConceptScore W2960897154C86803240 @default.
- W2960897154 hasConceptScore W2960897154C90924648 @default.
- W2960897154 hasConceptScore W2960897154C95190672 @default.
- W2960897154 hasIssue "Supplement 1" @default.
- W2960897154 hasLocation W29608971541 @default.
- W2960897154 hasOpenAccess W2960897154 @default.
- W2960897154 hasPrimaryLocation W29608971541 @default.
- W2960897154 hasRelatedWork W2017098107 @default.
- W2960897154 hasRelatedWork W2077564760 @default.
- W2960897154 hasRelatedWork W2113081116 @default.
- W2960897154 hasRelatedWork W2351420399 @default.
- W2960897154 hasRelatedWork W2357142827 @default.
- W2960897154 hasRelatedWork W2366793411 @default.
- W2960897154 hasRelatedWork W2387946178 @default.
- W2960897154 hasRelatedWork W2981957994 @default.
- W2960897154 hasRelatedWork W4303685354 @default.
- W2960897154 hasRelatedWork W4303945795 @default.
- W2960897154 hasVolume "132" @default.
- W2960897154 isParatext "false" @default.
- W2960897154 isRetracted "false" @default.
- W2960897154 magId "2960897154" @default.
- W2960897154 workType "article" @default.